Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody. Article Swipe

View

Tamara Mateu‐Albero , Raque Juárez-Sánchez , Cecilia Muñoz‐Calleja , Carlos Cuesta‐Mateos , Raque Juárez-Sánchez , Fernando Terrón , Carlos Cuesta‐Mateos , Javier Loscertales , Wim Mol , Fernando Terrón , Carlos Cuesta‐Mateos , Wim Mol , Cecilia Muñoz‐Calleja ·

YOU? · · 2021 · Open Access · · DOI: https://doi.org/10.24217/2531-0151.21v1s4.00040

Related Topics

Concepts

Ibrutinib Chronic lymphocytic leukemia C-C chemokine receptor type 7 Antibody Cancer research Leukemia Medicine Immunology Internal medicine Receptor Chemokine receptor Chemokine

Metadata

Type: article
Language: en
Landing Page: https://doi.org/10.24217/2531-0151.21v1s4.00040
OA Status: diamond
Related Works: 10
OpenAlex ID: https://openalex.org/W3173711538

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W3173711538

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.24217/2531-0151.21v1s4.00040

Digital Object Identifier
Title: Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody.

Work title
Type: article

OpenAlex work type
Language: en

Primary language
Publication year: 2021

Year of publication
Publication date: 2021-05-21

Full publication date if available
Authors: Tamara Mateu‐Albero, Raque Juárez-Sánchez, Cecilia Muñoz‐Calleja, Carlos Cuesta‐Mateos, Raque Juárez-Sánchez, Fernando Terrón, Carlos Cuesta‐Mateos, Javier Loscertales, Wim Mol, Fernando Terrón, Carlos Cuesta‐Mateos, Wim Mol, Cecilia Muñoz‐Calleja

List of authors in order
Landing page: https://doi.org/10.24217/2531-0151.21v1s4.00040

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: diamond

Open access status per OpenAlex
OA URL: https://doi.org/10.24217/2531-0151.21v1s4.00040

Direct OA link when available
Concepts: Ibrutinib, Chronic lymphocytic leukemia, C-C chemokine receptor type 7, Antibody, Cancer research, Leukemia, Medicine, Immunology, Internal medicine, Receptor, Chemokine receptor, Chemokine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W3173711538
doi	https://doi.org/10.24217/2531-0151.21v1s4.00040
ids.doi	https://doi.org/10.24217/2531-0151.21v1s4.00040
ids.mag	3173711538
ids.openalex	https://openalex.org/W3173711538
fwci	0.0
type	article
title	Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody.
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11157
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9987999796867371
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2716
topics[0].subfield.display_name	Genetics
topics[0].display_name	Chronic Lymphocytic Leukemia Research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2779878957
concepts[0].level	4
concepts[0].score	0.961484968662262
concepts[0].wikidata	https://www.wikidata.org/wiki/Q5984881
concepts[0].display_name	Ibrutinib
concepts[1].id	https://openalex.org/C2777938653
concepts[1].level	3
concepts[1].score	0.8350086212158203
concepts[1].wikidata	https://www.wikidata.org/wiki/Q1088156
concepts[1].display_name	Chronic lymphocytic leukemia
concepts[2].id	https://openalex.org/C127801297
concepts[2].level	5
concepts[2].score	0.5221143960952759
concepts[2].wikidata	https://www.wikidata.org/wiki/Q17907809
concepts[2].display_name	C-C chemokine receptor type 7
concepts[3].id	https://openalex.org/C159654299
concepts[3].level	2
concepts[3].score	0.5211979746818542
concepts[3].wikidata	https://www.wikidata.org/wiki/Q79460
concepts[3].display_name	Antibody
concepts[4].id	https://openalex.org/C502942594
concepts[4].level	1
concepts[4].score	0.5123194456100464
concepts[4].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[4].display_name	Cancer research
concepts[5].id	https://openalex.org/C2778461978
concepts[5].level	2
concepts[5].score	0.4063143730163574
concepts[5].wikidata	https://www.wikidata.org/wiki/Q29496
concepts[5].display_name	Leukemia
concepts[6].id	https://openalex.org/C71924100
concepts[6].level	0
concepts[6].score	0.4050251245498657
concepts[6].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[6].display_name	Medicine
concepts[7].id	https://openalex.org/C203014093
concepts[7].level	1
concepts[7].score	0.3215247094631195
concepts[7].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[7].display_name	Immunology
concepts[8].id	https://openalex.org/C126322002
concepts[8].level	1
concepts[8].score	0.24383985996246338
concepts[8].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[8].display_name	Internal medicine
concepts[9].id	https://openalex.org/C170493617
concepts[9].level	2
concepts[9].score	0.22823211550712585
concepts[9].wikidata	https://www.wikidata.org/wiki/Q208467
concepts[9].display_name	Receptor
concepts[10].id	https://openalex.org/C12823836
concepts[10].level	4
concepts[10].score	0.06881198287010193
concepts[10].wikidata	https://www.wikidata.org/wiki/Q24720618
concepts[10].display_name	Chemokine receptor
concepts[11].id	https://openalex.org/C13373296
concepts[11].level	3
concepts[11].score	0.0
concepts[11].wikidata	https://www.wikidata.org/wiki/Q421866
concepts[11].display_name	Chemokine
keywords[0].id	https://openalex.org/keywords/ibrutinib
keywords[0].score	0.961484968662262
keywords[0].display_name	Ibrutinib
keywords[1].id	https://openalex.org/keywords/chronic-lymphocytic-leukemia
keywords[1].score	0.8350086212158203
keywords[1].display_name	Chronic lymphocytic leukemia
keywords[2].id	https://openalex.org/keywords/c-c-chemokine-receptor-type-7
keywords[2].score	0.5221143960952759
keywords[2].display_name	C-C chemokine receptor type 7
keywords[3].id	https://openalex.org/keywords/antibody
keywords[3].score	0.5211979746818542
keywords[3].display_name	Antibody
keywords[4].id	https://openalex.org/keywords/cancer-research
keywords[4].score	0.5123194456100464
keywords[4].display_name	Cancer research
keywords[5].id	https://openalex.org/keywords/leukemia
keywords[5].score	0.4063143730163574
keywords[5].display_name	Leukemia
keywords[6].id	https://openalex.org/keywords/medicine
keywords[6].score	0.4050251245498657
keywords[6].display_name	Medicine
keywords[7].id	https://openalex.org/keywords/immunology
keywords[7].score	0.3215247094631195
keywords[7].display_name	Immunology
keywords[8].id	https://openalex.org/keywords/internal-medicine
keywords[8].score	0.24383985996246338
keywords[8].display_name	Internal medicine
keywords[9].id	https://openalex.org/keywords/receptor
keywords[9].score	0.22823211550712585
keywords[9].display_name	Receptor
keywords[10].id	https://openalex.org/keywords/chemokine-receptor
keywords[10].score	0.06881198287010193
keywords[10].display_name	Chemokine receptor
language	en
locations[0].id	doi:10.24217/2531-0151.21v1s4.00040
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4210181324
locations[0].source.issn	2531-0151
locations[0].source.type	journal
locations[0].source.is_oa	True
locations[0].source.issn_l	2531-0151
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	IBJ Plus
locations[0].source.host_organization	https://openalex.org/P4310322086
locations[0].source.host_organization_name	Iberoamerican Journals
locations[0].source.host_organization_lineage	https://openalex.org/P4310322086
locations[0].source.host_organization_lineage_names	Iberoamerican Journals
locations[0].license	cc-by-nc
locations[0].pdf_url
locations[0].version	publishedVersion
locations[0].raw_type	journal-article
locations[0].license_id	https://openalex.org/licenses/cc-by-nc
locations[0].is_accepted	True
locations[0].is_published	True
locations[0].raw_source_name	IBJ Plus
locations[0].landing_page_url	https://doi.org/10.24217/2531-0151.21v1s4.00040
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5089206368
authorships[0].author.orcid	https://orcid.org/0000-0003-2084-9629
authorships[0].author.display_name	Tamara Mateu‐Albero
authorships[0].author_position	first
authorships[0].raw_author_name	Tamara Mateu-Albero
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5073420492
authorships[1].author.orcid
authorships[1].author.display_name	Raque Juárez-Sánchez
authorships[1].author_position	middle
authorships[1].raw_author_name	Raque Juárez-Sánchez
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5051731658
authorships[2].author.orcid	https://orcid.org/0000-0003-4085-3115
authorships[2].author.display_name	Cecilia Muñoz‐Calleja
authorships[2].author_position	middle
authorships[2].raw_author_name	Cecilia MuñozCalleja
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5072403202
authorships[3].author.orcid	https://orcid.org/0000-0002-1576-9790
authorships[3].author.display_name	Carlos Cuesta‐Mateos
authorships[3].author_position	middle
authorships[3].raw_author_name	Carlos Cuesta-Mateos
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5073420492
authorships[4].author.orcid
authorships[4].author.display_name	Raque Juárez-Sánchez
authorships[4].author_position	middle
authorships[4].raw_author_name	Raque Juárez-Sánchez
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5042144484
authorships[5].author.orcid
authorships[5].author.display_name	Fernando Terrón
authorships[5].author_position	middle
authorships[5].raw_author_name	Fernando Terrón
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5072403202
authorships[6].author.orcid	https://orcid.org/0000-0002-1576-9790
authorships[6].author.display_name	Carlos Cuesta‐Mateos
authorships[6].author_position	middle
authorships[6].raw_author_name	Carlos Cuesta-Mateos
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5008703895
authorships[7].author.orcid
authorships[7].author.display_name	Javier Loscertales
authorships[7].author_position	middle
authorships[7].raw_author_name	Javier Loscertales
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5037142700
authorships[8].author.orcid
authorships[8].author.display_name	Wim Mol
authorships[8].author_position	middle
authorships[8].raw_author_name	Wim Mol
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5042144484
authorships[9].author.orcid
authorships[9].author.display_name	Fernando Terrón
authorships[9].author_position	middle
authorships[9].raw_author_name	Fernando Terrón
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5072403202
authorships[10].author.orcid	https://orcid.org/0000-0002-1576-9790
authorships[10].author.display_name	Carlos Cuesta‐Mateos
authorships[10].author_position	middle
authorships[10].raw_author_name	Carlos Cuesta-Mateos
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5037142700
authorships[11].author.orcid
authorships[11].author.display_name	Wim Mol
authorships[11].author_position	middle
authorships[11].raw_author_name	Wim Mol
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5051731658
authorships[12].author.orcid	https://orcid.org/0000-0003-4085-3115
authorships[12].author.display_name	Cecilia Muñoz‐Calleja
authorships[12].author_position	last
authorships[12].raw_author_name	Cecilia MuñozCalleja
authorships[12].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.24217/2531-0151.21v1s4.00040
open_access.oa_status	diamond
open_access.any_repository_has_fulltext	False
created_date	2021-07-05T00:00:00
display_name	Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia, a novel therapeutic anti-CCR7 antibody.
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11157
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9987999796867371
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2716
primary_topic.subfield.display_name	Genetics
primary_topic.display_name	Chronic Lymphocytic Leukemia Research
related_works	https://openalex.org/W2264345925, https://openalex.org/W3161155926, https://openalex.org/W2970030949, https://openalex.org/W4238721786, https://openalex.org/W3043694179, https://openalex.org/W4296613604, https://openalex.org/W2035536649, https://openalex.org/W3113020443, https://openalex.org/W4377088465, https://openalex.org/W4310104970
cited_by_count	0
locations_count	1
best_oa_location.id	doi:10.24217/2531-0151.21v1s4.00040
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4210181324
best_oa_location.source.issn	2531-0151
best_oa_location.source.type	journal
best_oa_location.source.is_oa	True
best_oa_location.source.issn_l	2531-0151
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	IBJ Plus
best_oa_location.source.host_organization	https://openalex.org/P4310322086
best_oa_location.source.host_organization_name	Iberoamerican Journals
best_oa_location.source.host_organization_lineage	https://openalex.org/P4310322086
best_oa_location.source.host_organization_lineage_names	Iberoamerican Journals
best_oa_location.license	cc-by-nc
best_oa_location.pdf_url
best_oa_location.version	publishedVersion
best_oa_location.raw_type	journal-article
best_oa_location.license_id	https://openalex.org/licenses/cc-by-nc
best_oa_location.is_accepted	True
best_oa_location.is_published	True
best_oa_location.raw_source_name	IBJ Plus
best_oa_location.landing_page_url	https://doi.org/10.24217/2531-0151.21v1s4.00040
primary_location.id	doi:10.24217/2531-0151.21v1s4.00040
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4210181324
primary_location.source.issn	2531-0151
primary_location.source.type	journal
primary_location.source.is_oa	True
primary_location.source.issn_l	2531-0151
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	IBJ Plus
primary_location.source.host_organization	https://openalex.org/P4310322086
primary_location.source.host_organization_name	Iberoamerican Journals
primary_location.source.host_organization_lineage	https://openalex.org/P4310322086
primary_location.source.host_organization_lineage_names	Iberoamerican Journals
primary_location.license	cc-by-nc
primary_location.pdf_url
primary_location.version	publishedVersion
primary_location.raw_type	journal-article
primary_location.license_id	https://openalex.org/licenses/cc-by-nc
primary_location.is_accepted	True
primary_location.is_published	True
primary_location.raw_source_name	IBJ Plus
primary_location.landing_page_url	https://doi.org/10.24217/2531-0151.21v1s4.00040
publication_date	2021-05-21
publication_year	2021
referenced_works_count	0
abstract_inverted_index
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	13
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.6700000166893005
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.09567437
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False